| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |